Caps Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 9.64%
- Profit Growth -42.46%
- Ebitda -8.08%
- Net Worth 2.20%
- Total Assets -4.07%
About Caps Pharma
Caps Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 December 2011 and has a history of 13 years and one month. Its registered office is in New Delhi, India.
The Corporate was formerly known as Caps Pharma Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chander Dhall, Poonam Dhall, Abhinav Kumar, and One other member serve as directors at the Company.
Company Details
- Location
New Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51909DL2011PTC228386
- Company No.
228386
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Caps Pharma Private Limited offer?
Caps Pharma Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Protein Powder.
Who are the key members and board of directors at Caps Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chander Dhall  | Director | 09-May-2017 | Current |
| Poonam Dhall | Director | 01-Dec-2017 | Current |
| Abhinav Kumar | Director | 07-Dec-2011 | Current |
| Siddhanta Kumar | Director | 20-Jul-2020 | Current |
Financial Performance of Caps Pharma.
Caps Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.64% increase. The company also saw a substantial fall in profitability, with a 42.46% decrease in profit. The company's net worth moved up by a moderate rise of 2.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Caps Pharma?
Unlock access to Caps Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
_LIMITED.webp)
Atlas Cycles (Haryana) LimitedChander Dhall is a mutual person
Cee Pee Creations Private LimitedChander Dhall, Poonam Dhall and 1 more are mutual person
- Caps Tradelink Private Limited
Chander Dhall, Poonam Dhall and 2 more are mutual person
- B B Creations Private Limited
Chander Dhall and Poonam Dhall are mutual person
- Caps Lifesciences Private Limited
Abhinav Kumar and Siddhanta Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Caps Pharma?
Unlock and access historical data on people associated with Caps Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Caps Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Caps Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
